Literature DB >> 12776274

Insulin resistance is related to left ventricular hypertrophy in patients with polycystic kidney disease type 1.

Anne Lumiaho1, Jussi Pihlajamäki, Juha Hartikainen, Risto Ikäheimo, Raija Miettinen, Lea Niemitukia, Erkki Lampainen, Markku Laakso.   

Abstract

BACKGROUND: Left ventricular hypertrophy (LVH) is common in patients with autosomal dominant polycystic kidney disease (ADPKD). Although insulin resistance contributes to cardiac hypertrophy, the relationship between insulin resistance and LVH in patients with ADPKD has not been previously studied.
METHODS: We performed M-mode and color Doppler echocardiography on 176 family members (106 patients and 70 healthy relatives) from 16 families with polycystic kidney disease type 1 (PKD1). Left ventricular mass index (LVMI) was calculated using the Penn equation and corrected for body surface area. Fasting insulin and glucose concentrations were measured and insulin resistance was evaluated by means of the homeostasis model assessment.
RESULTS: In multivariate regression analysis, insulin resistance was significantly associated with LVMI in healthy relatives (P < 0.01) and patients with PKD1 (P < 0.05) independent of age, weight, systolic blood pressure, and albuminuria.
CONCLUSION: Insulin resistance is associated with LVMI in patients with PKD1 independently of other factors known to increase LVMI.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12776274     DOI: 10.1016/s0272-6386(03)00354-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  10 in total

1.  Hypertension in Autosomal Dominant Polycystic Kidney Disease: A Clinical and Basic Science Perspective.

Authors:  Shobha Ratnam; Surya M Nauli
Journal:  Int J Nephrol Urol       Date:  2010

2.  The relation of anthropometric measurements and insulin resistance in patients with polycystic kidney disease.

Authors:  Bennur Esen; Emel Sağlam Gokmen; Mahmut Kaya; Burak Ozkan; Ahmet Engin Atay
Journal:  J Transl Int Med       Date:  2016-09-23

Review 3.  Hypertension in autosomal dominant polycystic kidney disease.

Authors:  Arlene B Chapman; Konrad Stepniakowski; Frederic Rahbari-Oskoui
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

4.  Epicardial Fat Thickness in Patients with Autosomal Dominant Polycystic Kidney Disease.

Authors:  Antonio Concistrè; Luigi Petramala; Gianmarco Scoccia; Susanna Sciomer; Valeria Bisogni; Vincenza Saracino; Gino Iannucci; Silvia Lai; Daniela Mastroluca; Gianluca Iacobellis; Claudio Letizia
Journal:  Cardiorenal Med       Date:  2018-05-03       Impact factor: 2.041

Review 5.  Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease.

Authors:  Tevfik Ecder; Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

6.  Cardiac function assessed by myocardial deformation in adult polycystic kidney disease patients.

Authors:  Mats C H Lassen; Atif N Qasim; Tor Biering-Sørensen; Jacob L T Reeh; Terry Watnick; Stephen L Seliger; Huanwen Chen; Mariem A Sawan; Daniel Nguyen; Yongfang Li; Susie N Hong; Meyeon Park
Journal:  BMC Nephrol       Date:  2019-08-16       Impact factor: 2.388

7.  A Systematic Review of Reported Outcomes in ADPKD Studies.

Authors:  Sara S Jdiaa; Nedaa M Husainat; Razan Mansour; Mohamad A Kalot; Kerri McGreal; Fouad T Chebib; Ronald D Perrone; Alan Yu; Reem A Mustafa
Journal:  Kidney Int Rep       Date:  2022-07-05

8.  Neutrophil-to-lymphocyte ratio, insulin resistance, and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease.

Authors:  K Turkmen; F Tufan; E Selçuk; T Akpınar; H Oflaz; T Ecder
Journal:  Indian J Nephrol       Date:  2013-01

9.  Developments in the management of autosomal dominant polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Mir Reza Bekheirnia; Robert W Schrier
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

10.  Effects of insulin resistance on left ventricular hypertrophy in patients with CKD stage 1-3.

Authors:  Cheng-jun Wang; Xiao-rong Bao; Guo-wei Du; Yu Wang; Kai Chen; Ma-li Shen; Li-zhen Wang
Journal:  Int Urol Nephrol       Date:  2014-05-18       Impact factor: 2.370

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.